Your browser doesn't support javascript.
loading
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
Kelley, Robin K; Joseph, Nancy M; Nimeiri, Halla S; Hwang, Jimmy; Kulik, Laura M; Ngo, Zoe; Behr, Spencer C; Onodera, Courtney; Zhang, Karen; Bocobo, Andrea G; Benson, Al B; Venook, Alan P; Gordan, John D.
Afiliação
  • Kelley RK; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Joseph NM; Department of Pathology, University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Nimeiri HS; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Hwang J; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Kulik LM; Division of Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Ngo Z; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Behr SC; Department of Radiology, University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Onodera C; Clinical Cancer Genomics Lab, UCSF Health, San Francisco, California, USA.
  • Zhang K; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Bocobo AG; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Benson AB; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Venook AP; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
  • Gordan JD; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.
Liver Cancer ; 10(6): 561-571, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34950179
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article